Beneficial Effects of Natural Products on Management of Xerostomia
NCT06217614 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2024-05-09
Summary
Xerostomia, the subjective feeling of oral dryness, is a symptom most frequently accompanied by either decreased salivary flow or an altered composition of saliva. Hyposalivation, on the other hand, is the objective measured reduction in salivary flow rate. Xerostomia is a relatively common complaint, particularly among older people, and can lead to major consequences with regard to the quality of their general and oral health and wellbeing.
Xerostomia has a variety of possible etiological factors; it is generally classified as having primary and secondary causes. Primary causes comprise conditions that directly affect the salivary glands and induce xerostomia like, Sjogren's syndrome, diabetes mellitus type 1 and 2, thyroid disease, adrenal pathology, renal or hepatic diseases, hepatitis C virus infection, and HIV disease.
Conditions
- Xerostomia
- Diabetes Mellitus
- Hypertension
- Post COVID-19 Condition
Interventions
- OTHER
-
(Manuka honey-green tea)
Manuka honey is a natural honey, and green tea are herbs Dried green tea leaves (100 gm) will be soaked into 500 ml of methanol solution for two days. Green tea plus ginger mouthwash was prepared by adding 50% green tea extract and 50% ginger extract. After extraction, the extract was filtered and taker to the vacuum evaporator to remove the solvent. The mouthwash was prepared by adding 3 gm of each extract, 0.12 gm sodium saccharin, and one liter distilled water, then every 20 ml of Manuka honey were added in 100 ml of (green tea and ginger solution). Finally, the mixture was stirred vigorously until all the particles were dissolved. Thereafter the obtained mixture was filtered. The mouthwash then filled in sterilized amber color bottles of 250 ml each. According to similar studies performed in this field, the patients used a 20ml of (Manuka honey-green tea- ginger) mouthwash three times a day (preferably after their meals), kept it for one minute, and then poured it out
Sponsors & Collaborators
-
British University In Egypt
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-01
- Primary Completion
- 2022-09-01
- Completion
- 2022-10-01
Countries
- Egypt
Study Locations
More Related Trials
-
Clinical Evaluation of Oral Rinse for Xerostomia
NCT04289051 ·Status: COMPLETED ·Phase: NA
-
CLINICAL EVALUATION OF THE EFFICACY OF AN INTRA ORAL SPRAY FOR PATIENTS WITH XEROSTOMIA
NCT04719091 ·Status: COMPLETED ·Phase: NA
-
Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients
NCT06984848 ·Status: RECRUITING ·Phase: NA
-
Treatment of Xerostomia by Herbal Preparation
NCT01579877 ·Status: UNKNOWN ·Phase: NA
-
Photobiomodulation in Salivary Production of Patients With Xerostomy
NCT03632096 ·Status: UNKNOWN ·Phase: PHASE2
-
Xerostomia in Patients With a Life-limiting Condition or Frailty
NCT05506137 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Natural Antibacterial Mouthwash on Taste, Salivary pH and Bacteria in High Caries Risk pt
NCT03623048 ·Status: UNKNOWN ·Phase: NA
-
Efficacy Study of Oxygenated Glycerol Triesters to Treat Xerostomia
NCT00332618 ·Status: COMPLETED
-
Effect of Pilocarpine in Patients With Xerostomia
NCT02982577 ·Status: UNKNOWN ·Phase: PHASE4
-
Chamomile Effect on Xerostomia Associated With End-stage Renal Disease in Elderly
NCT06114797 ·Status: COMPLETED ·Phase: NA
-
Interest of the Sialendoscopy Associated With a Local Injection of Corticosteroids in the Treatment of Radio-induced Xerostomia in Comparison With the Hygiene Rules
NCT04584164 ·Status: RECRUITING ·Phase: NA
-
"Hyaluronan" Formulation for Type 2 Diabetic Patients With Dry Mouth
NCT03281486 ·Status: COMPLETED ·Phase: NA
-
Effect of Saliva Substitutes on Dental Hard Tissues in Situ
NCT01165970 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Effect of Photobiomodulation for Patients With Xerostomia
NCT05336981 ·Status: COMPLETED ·Phase: NA
-
Drug-induced Xerostomia. Evaluation of Malic Acid 1%, Salivary Mucins and Buffering Capacity
NCT01652001 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Natural Enzymes Mouthwash: a Randomised Controlled Trial
NCT05640362 ·Status: COMPLETED ·Phase: NA
-
Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms
NCT02641912 ·Status: COMPLETED ·Phase: NA
-
Topical Management of Xerostomia With Dry Mouth Products
NCT03611283 ·Status: COMPLETED ·Phase: NA
-
"Hyaluronan" Formulation for Dry Mouth in Sleep Apnea Patients
NCT03295019 ·Status: UNKNOWN ·Phase: NA
-
Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients
NCT06703372 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Novel Edible Gel-based Artificial Saliva in Thai Geriatric Populations With Systemic Diseases
NCT02317172 ·Status: COMPLETED ·Phase: NA
-
Tolerance and Efficiency of an Intrabuccal Biological Film to Enhance Oral Dryness Sensation: The "PREDELFI" Clinical Pilot Study
NCT04206826 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Interest of the Buccal Schirmer Test in Xerostomia During Sjögren's Syndrome: XERODIAG
NCT06530940 ·Status: NOT_YET_RECRUITING
-
Effects of a Salivary Gland Massage Program on Salivary Flow , Xerostomia, Chewing, and Swallowing, and Oral Health Among Community- Dwelling Older Adults
NCT07251543 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva
NCT01690052 ·Status: COMPLETED ·Phase: NA